Drug Trial Radar · NCT00029822
Clinical Trial in Males With BPH (Enlarged Prostate)
Last checked: Nov 20, 2026Latest source record: Jun 9, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,522
Actual
Start
May 2001
Primary completion
Not stated
Study completion Mar 2005
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jan 24, 2002
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Prevention
- Who can join
- Male only, from 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to determine the effect on prevention of Acute Urinary Retention (inability to urinate) in males with an enlarged prostate, also known as BPH. * Free study-related medical care provided.
Conditions
- Urinary Retention
- Prostatic Hyperplasia
- Benign Prostatic Hypertrophy
Interventions
Alfuzosin (SL770499)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- occurrence of first episode of acute urinary retention (AUR)
Locations
54 sites in 17 countries. Site status is shown where the registry gives one.
Medical Affiliated Research Center, Inc
Huntsville, Alabama
San Diego Urology Center
La Mesa, California
San Bernardino Urology Associates
San Bernardino, California
San Diego Urological Medical Group
San Diego, California
Pacific Clinical Research
Santa Monica, California
Urology Research Options
Aurora, Colorado
Connecticut Clinical Research Center
Waterbury, Connecticut
South Florida Medical Research
Aventura, Florida
Tampa Bay Medical Research, Inc.
Clearwater, Florida
Advanced Research Institute
New Port Richey, Florida
Renstar Medical Research
Ocala, Florida
Renstar Medical Research
Plantation, Florida
Urology Associates
Marietta, Georgia
Northwestern Center for Clinical Research
Chicago, Illinois
Welborn Clinic
Evansville, Indiana
Northeast Indiana Research
Fort Wayne, Indiana
Urology of Indiana, LLC
Indianapolis, Indiana
Maryland Prostate Cancer
Baltimore, Maryland
Maryland Urology Association
Towson, Maryland
Newton Wellesley Urology
Newton, Massachusetts
Lakeside Urology, P.C.
Saint Joseph, Michigan
Se Urology Network
Southaven, Mississippi
Weill Cornell Medical Center
New York, New York
Advanced Clinical Trials
Eugene, Oregon
Albert Einstein Medical Center
Philadelphia, Pennsylvania
Center for Urologic Care
West Reading, Pennsylvania
Matrix Research
Greenville, South Carolina
Ut Medical Group, Inc.
Memphis, Tennessee
Murfreesboro Medical Center
Murfreesboro, Tennessee
nTouch Research Corporation
Dallas, Texas
Urology Consultants, P.A.
San Antonio, Texas
Urology Associates
Fredericksburg, Virginia
Jeffrey Frankel
Seattle, Washington
University of Wisconsin Hospital & Clinics
Madison, Wisconsin
Midwest Research Specialists, LLC
Milwaukee, Wisconsin
Sanofi-aventis Administrative Office
Macquarie Park, Australia
Sanofi-aventis Administrative Office
Sofia, Bulgaria
Sanofi-aventis Administrative Office
Laval, Canada
Sanofi-aventis Administrative Office
Hørsholm, Denmark
Sanofi-aventis Administrative Office
Helsinki, Finland
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.